Clinical Trial Update: Infusion of PD1/PDL1/CTLA4 Inhibitors Via Hepatic Arterial for Immunotherapy of Hepatocellular Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating infusion of PD-1/PD-L1/CTLA-4 inhibitors via hepatic artery for hepatocellular carcinoma; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Second Affiliated Hospital of Guangzhou Medical University | Conditions: Liver Cancer | Phase 3 | Status: RECRUITING